Lilly's 2025 guidance of USD 5861 billion implies continued 32% growth momentum, validated by the SURMOUNT-5 Phase 3b head-to-head trial result: Zepbound demonstrated 47% greater relative weight loss compared to Wegovy the most commercially consequential head-to-head data in the obesity market
Other ingredients Purified water, malic acid, natural and artificial flavor, phosphoric acid, sucralose, acesulfame potassium, potassium sorbate (preservative), sodium benzoate (preservative)
benzyl alcohol) or other excipients that can provoke sensitivity
Weight loss injection costs depend on the medication type, brand status, dose, insurance coverage, and whether the provider bundles medical care with the medication
TRIUMPH-OUTCOMES (NCT06383390) will investigate the impact of retatrutide vs